Clinical trials update from the American Heart Association meeting: PROSPER, DIAL, home care monitoring trials, immune modulation therapy, COMPANION and anaemia in heart failure.
This article continues a series of reports on research developments of particular interest to those involved in the management of patients with heart failure. Summaries of the following trials, reported at the 75th Scientific Sessions of the American Heart Association held in Chicago, Illinois between 17th and 20th November 2002 are included: PROSPER; DIAL; home care monitoring trials; immune modulation therapy; COMPANION; and anaemia in heart failure.
Coletta
A P
AP
Department of Academic Cardiology, Castle Hill Hospital, Cottingham, Kingston upon Hull HU16 5JQ, UK. a.p.coletta@hull.ac.uk
Nikitin
N
N
Clark
A L
AL
Cleland
J G F
JG
D000572:American Heart Association; D000740:Anemia / Q000175:diagnosis / Q000628:therapy; D006126:Group Processes; D006333:Heart Failure / Q000175:diagnosis / Q000628:therapy; D006699:Home Care Services; D006801:Humans; D007167:Immunotherapy; D008991:Monitoring, Physiologic; D014481:United States